RARA CRAFT DATABASE for FDA Medical Devices
510(k)K190290

FDA DEVICE FACTS

AltiVate Reverse Humeral Stem, 48mm

Encore Medical L.P.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 26, 2019PRODUCT CODEKWS

Indications for use

Anatomic Total Shoulder Indications: The AltiVate Reverse Humeral Stem is indicated as an Anatomic shoulder joint replacement for patients suffering from pain and dysfunctio n due to:

• Noninflammatory degenerative joint disease including osteoarthritis;

• Inflammatory arthritis of the glenohumeral join including rheumatoid arthritis;

• Post-traumatic arthritis of the glenohumeral joint;

• Avascular necrosis of the humeral head with and without involvement of the glenoid;

• Correction of functional deformity The all-poly glenoid is intended for cemented use. Hemi Shoulder Indicatio ns : The AltiVate Reverse Humeral Stem is indicated as a hemi shoulder joint replacement for patients suffering from pain and dysfunctio n due to:

• Noninflammatory degenerative joint disease including osteoarthritis;

• Inflammatory arthritis of the glenohumeral joint includ ing rheumato id arthritis;

• Post-traumatic arthritis of the glenohumeral joint;

• Avascular necrosis of the humeral head with and without involvement of the glenoid;

• Correction of functional deformity;

• Rotator cuff tear arthropathy;

• Humeral fracture;

• Failed previous shoulder surgery. Reverse Total Shoulder Indications: The AltiVate Reverse Humeral Stem is as a reverse shoulder replacement for patients with a functional deltoid muscle and a grossly deficient rotator cuff joint suffer ing from pain and dysfunctio n due to:

• Severe arthropathy with a grossly deficient rotator cuff;

• Previously failed joint replacement with a grossly deficient rotator cuff;

• Fracture of glenohumeral joint from trauma or pathologic conditions of the shoulder includ ing humeral head fracture, displaced 3- or 4-part fractures of proximal humerus, or reconstructio n after tumor resection;

• Bone defect in proximal humerus;

•N o n-inflammatory degenerative disease including osteoarthritis and avascular necrosis of the natural humeral head and/or glenoid;

• Inflammatory arthritis including rheumatoid arthritis;

• Correction of functio nal deformity. The glenoid baseplate is intended for cementless application with addition of screws for fixation. This device may also be indicated in the salvage of previously failed surgical attempts for anatomic and hemi procedures. All humeral stems are intended for cemented or cementless use.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 25, 2026